News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Study Results of Novocure’s Pivotal Phase 3 Trial Published in European Journal of Cancer Show that NovoTTF™ Therapy was Comparable to Physicians’ First Chemotherapy Choice in Clinical Efficacy with Better Quality of Life Outcomes in Patients with Recurrent Glioblastoma


Posted on: 05/21/2012

Study Results of Novocure’s Pivotal Phase 3 Trial 

Published in European Journal of Cancer Show that 

NovoTTF™ Therapy was Comparable to Physicians’ First 

Chemotherapy Choice in Clinical Efficacy with Better 

Quality of Life Outcomes in Patients with Recurrent 

Glioblastoma 

Click HERE to read the press release!

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740